Latest Insider Transactions at Denali Therapeutics Inc. (DNLI)
This section provides a real-time view of insider transactions for Denali Therapeutics Inc. (DNLI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Denali Therapeutics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Denali Therapeutics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 12
2017
|
Fil LTD |
BUY
Conversion of derivative security
|
Direct |
1,497,951
+16.22%
|
-
|
|
Dec 12
2017
|
Douglas K Bratton > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
275,000
+1.39%
|
$4,950,000
$18.0 P/Share
|
|
Dec 12
2017
|
Douglas K Bratton > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
19,986,798
+25.26%
|
-
|
|
Dec 12
2017
|
Flagship Ventures Fund V, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
8,606,249
+49.11%
|
-
|